首页 › 股票 › RADX

RADX — Radiopharm Theranostics Ltd

申报持仓市值$2.80M
持有基金数(最新)14
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q3 2026)7
机构持仓市值$1.00M · 621.69K 股
新建/增持/减仓/清仓2 / 1 / 2 / 2 · 更新于 2026-11-17
前五大/前十大集中度99.8% / 100.0%
机构整体持仓变动 减持 -8.5% (-10.49K 股)
机构持仓市值变动 下降 -64.6%

华尔街分析师共识

评级、12 个月目标价与 EPS 预期,来自 Nasdaq 公开分析师数据接口。 · 抓取于 2026-11-19

共识评级Strong Buy
覆盖分析师—
12 个月目标价$15.50 (+1941.1%)
抓取时现价$0.76
前瞻市盈率(FY1)—
前瞻市盈率(FY2)—
修正分(季度)—
修正分(年度)+0.00
财年截止 共识 EPS 预期 前瞻市盈率 最高 EPS 最低 EPS 预测机构数 近 4 周修正(上调/下调)
Jun 2027 -3.23 — -3.23 -3.23 1 —

前瞻市盈率 = 抓取时现价 ÷ 共识 EPS(季度数据 ×4 年化)。修正分 =(上调 − 下调)÷ 预测机构数,来自 Nasdaq 近 4 周统计。 来源: Nasdaq analyst data

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

截至Q3 2026,共 7 家机构在其最新 13F 申报中持有 RADX(Radiopharm Theranostics Ltd),合计申报市值 $1.00M,对应 621.69K 股。按股数计算较上季度减持 8.5%(-10.49K 股),申报市值环比下降 64.6%。持仓集中度较高:前五大持有人占申报市值的 99.8%,前十大的集中度为 100.0%。

与上一季度相比,2 家新建仓位、1 家加仓、2 家减仓、2 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q3 2026 末的持仓状态,并非实时交易。

Radiopharm Theranostics Ltd(RADX)的主要机构持有人包括 SILVERARC CAPITAL MANAGEMENT, LLC、ARMISTICE CAPITAL, LLC、Stonepine Capital Management, LLC,按 13F 申报市值在本页 14 家持有人中排名居前。

RADX 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 7 621.69K $1.00M -8.5%
Q2 2026 7 51.13M $1.19M +0.0%
Q1 2026 7 51.31M $2.06M -0.4%
Q4 2025 11 51.54M $3.67M -1.3%
Q3 2025 4 312.51K $1.73M +2.8%
Q2 2025 5 339.69K $1.58M -8.4%
Q1 2025 3 342.92K $1.65M -21.1%
Q4 2024 4 435.80K $1.94M —

表内 8 个季度中,机构持股合计增加 43%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2025(-21.1%)。

前 25 大机构持仓人(Q3 2026) — 7 家基金

基金股数金额组合权重变化
ARMISTICE CAPITAL, LLC 450.00K $729.00K 0.01% 新进
Marex Group Ltd 58.15K $94.21K 0.00% 新进
PNC Financial Services 50.00K $81.00K 0.00% 增持
Regal Partners Ltd 39.98K $64.76K 0.00% 持有
HSBC HOLDINGS PLC 22.48K $33.95K 0.00% 减持
UBS Group AG 883 $1.43K 0.00% 减持
RHUMBLINE ADVISERS 195 $315 0.00% 持有

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 7 家基金

基金股数金额组合权重变化
Stonepine Capital Management, LLC 51.00M $670.50K 0.44% 持有
HSBC HOLDINGS PLC 62.19K $253.73K 0.00% 增持
Regal Partners Ltd 40.14K $168.18K 0.01% 持有
PNC Financial Services 20.00K $83.80K 0.00% 增持
UBS Group AG 1.51K $6.31K 0.00% 减持
Integrated Wealth Concepts LLC 1.31K $5.49K 0.00% 新进
RHUMBLINE ADVISERS 195 $817 0.00% 增持

Q1 2026 — 7 家基金

基金股数金额组合权重变化
SILVERARC CAPITAL MANAGEMENT, LLC 187.41K $805.85K 0.10% 持有
Stonepine Capital Management, LLC 51.00M $738.98K 0.44% 持有
HSBC HOLDINGS PLC 61.37K $264.51K 0.00% 减持
Regal Partners Ltd 40.14K $172.59K 0.01% 减持
PNC Financial Services 16.00K $68.80K 0.00% 持有
UBS Group AG 3.00K $12.90K 0.00% 减持
RHUMBLINE ADVISERS 121 $519 0.00% 增持

Q4 2025 — 11 家基金

基金股数金额组合权重变化
HSBC HOLDINGS PLC 191.62K $1.01M 0.00% 新进
SILVERARC CAPITAL MANAGEMENT, LLC 187.41K $978.26K 0.15% 持有
Stonepine Capital Management, LLC 51.00M $850.85K 0.66% 新进
Regal Partners Ltd 90.91K $474.55K 0.03% 持有
PNC Financial Services 16.00K $83.52K 0.00% 持有
Virtu Financial LLC 14.59K $76.00K 0.00% 新进
JANE STREET GROUP, LLC 14.47K $75.53K 0.00% 新进
UBS Group AG 14.28K $74.53K 0.00% 减持
Marex Group Ltd 10.29K $53.69K 0.00% 新进
Strategic Wealth Partners, Ltd. 10 $52 0.00% 新进
RHUMBLINE ADVISERS 6 $31 0.00% 新进

Q3 2025 — 4 家基金

基金股数金额组合权重变化
SILVERARC CAPITAL MANAGEMENT, LLC 187.41K $1.03M 0.15% 持有
Regal Partners Ltd 90.91K $501.82K 0.04% 持有
UBS Group AG 18.19K $100.41K 0.00% 增持
PNC Financial Services 16.00K $88.32K 0.00% 增持

Q2 2025 — 5 家基金

基金股数金额组合权重变化
SILVERARC CAPITAL MANAGEMENT, LLC 187.41K $869.56K 0.18% 持有
Regal Partners Ltd 90.91K $421.82K 0.04% 持有
Affinity Asset Advisors, LLC 35.63K $166.06K 0.03% 减持
UBS Group AG 17.74K $82.31K 0.00% 新进
PNC Financial Services 8.00K $37.12K 0.00% 新进

新建仓(Q3 2026)

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 14 只基金)

基金Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
ARMISTICE CAPITAL, LLC 450.00K — — — — — — —
Marex Group Ltd 58.15K — — 10.29K — — — —
PNC Financial Services 50.00K 20.00K 16.00K 16.00K 16.00K 8.00K — —
Regal Partners Ltd 39.98K 40.14K 40.14K 90.91K 90.91K 90.91K 90.91K 90.91K
HSBC HOLDINGS PLC 22.48K 62.19K 61.37K 191.62K — — — —
UBS Group AG 883 1.51K 3.00K 14.28K 18.19K 17.74K — 1.32K
RHUMBLINE ADVISERS 195 195 121 6 — — — —
SILVERARC CAPITAL MANAGEMENT, LLC — — 187.41K 187.41K 187.41K 187.41K 187.41K 187.41K
Stonepine Capital Management, LLC — 51.00M 51.00M 51.00M — — — —
Affinity Asset Advisors, LLC — — — — — 35.63K 64.60K 156.17K
Virtu Financial LLC — — — 14.59K — — — —
JANE STREET GROUP, LLC — — — 14.47K — — — —
Integrated Wealth Concepts LLC — 1.31K — — — — — —
Strategic Wealth Partners, Ltd. — — — 10 — — — —

下载持有人名单 (CSV)

常见问题

Which funds hold RADX?

As of 2026-Q3, 7 institutional funds reported holding RADX (Radiopharm Theranostics Ltd) in SEC 13F filings, with a combined reported value of $1.00M.

How many shares of RADX do institutions own?

13F filers reported 621.69K shares of RADX, worth $1.00M in aggregate at the end of 2026-Q3.

Is institutional ownership of RADX rising or falling?

Share counts moved -8.5% versus the prior quarter — distribution.

Who are the top institutional holders of RADX?

The largest 13F holders are SILVERARC CAPITAL MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, Stonepine Capital Management, LLC, Affinity Asset Advisors, LLC, Marex Group Ltd; the top 25 are ranked at the top of this page.

Who are the major shareholders of Radiopharm Theranostics Ltd?

The major shareholders of Radiopharm Theranostics Ltd (RADX) by reported 13F value are SILVERARC CAPITAL MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, Stonepine Capital Management, LLC, Affinity Asset Advisors, LLC, Marex Group Ltd, among 14 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 RADX」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/RADX/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →